↓ Skip to main content

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, May 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
107 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
Published in
European Journal of Nuclear Medicine and Molecular Imaging, May 2020
DOI 10.1007/s00259-020-04859-y
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 107 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 15 14%
Student > Ph. D. Student 10 9%
Other 8 7%
Student > Master 6 6%
Student > Bachelor 4 4%
Other 15 14%
Unknown 49 46%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 27 25%
Biochemistry, Genetics and Molecular Biology 6 6%
Chemistry 6 6%
Neuroscience 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 9 8%
Unknown 52 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2020.
All research outputs
#14,591,600
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#1,749
of 3,083 outputs
Outputs of similar age
#213,524
of 393,343 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#35
of 81 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,343 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.